Advocacy intelligence hub — real-time data for patient organizations
Massachusetts General Hospital — NA
Columbia University — NA
Chang Gung Memorial Hospital — NA
Wei XIA, PhD
University of Alabama at Birmingham — PHASE4
Centre for Infectious Disease Research in Zambia — NA
Massachusetts General Hospital — NA
University of Edinburgh
University of Edinburgh
Izmir Democracy University — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Pulmozyme
Genentech, Inc.
Pulmozyme
(Dornase alfa)Orphan drugstandardGenentech, Inc.
Recombinant Human Deoxyribonuclease 1 [EPC]
12.1 Mechanism of Action PULMOZYME is recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA. In preclinical in vitr...
Heather J Symons, M.D
Children's Oncology Group
📍 BALTIMORE, MD
Susan K. Parsons, MD, MRP
Tufts Medical Center Cancer Center
Henrietta S Bada, MD MPH, MD
University of Kentucky
📍 LEXINGTON, KY
Staci M Peron, Ph.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
Michael E Newcomb, Ph.D.
Northwestern University
Jim Carey, MPH
Northwestern University